Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7539
+0.0045 (0.60%)
Sep 17, 2025, 3:23 PM EDT - Market open
Longeveron Market Cap
Longeveron has a market cap or net worth of $15.88 million as of September 17, 2025. Its market cap has decreased by -47.09% in one year.
Market Cap
15.88M
Enterprise Value
6.59M
1-Year Change
-47.09%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $15.88M, a decrease of -90.79%. That is a compound annual growth rate of -40.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 15.78M | -38.51% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |